EXANE DERIVATIVES - ARENA PHARMACEUTICALS INC ownership

ARENA PHARMACEUTICALS INC's ticker is ARNA and the CUSIP is 040047607. A total of 259 filers reported holding ARENA PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.76 and the average weighting 0.2%.

Quarter-by-quarter ownership
EXANE DERIVATIVES ownership history of ARENA PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2021$33,085,000
-77.1%
356
-85.3%
0.01%
-77.1%
Q3 2021$144,582,000
+57.4%
2,428
+76.5%
0.04%
+66.7%
Q2 2021$91,860,000
+166.9%
1,376
+207.1%
0.02%
+110.0%
Q4 2020$34,418,000
-14.0%
448
-16.3%
0.01%
-16.7%
Q3 2020$40,010,000
+18.8%
5350.0%0.01%
+33.3%
Q2 2020$33,676,000
+49.9%
5350.0%0.01%
+50.0%
Q1 2020$22,469,000
-46.8%
535
-42.8%
0.01%
-25.0%
Q4 2019$42,239,000
-80.3%
935
-80.0%
0.01%
-78.9%
Q3 2019$213,979,000
-32.1%
4,676
-13.1%
0.04%
-30.9%
Q2 2019$315,250,0005,3790.06%
Other shareholders
ARENA PHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
HUNTINGTON NATIONAL BANK 1$00.00%
IFP Advisors, Inc 2$1,0000.00%
View complete list of ARENA PHARMACEUTICALS INC shareholders